FDA Selects Seven Firms for PreCheck Manufacturing Pilot
SILVER SPRING, Md., June 29, 2026 The U.S. Food and Drug Administration (FDA) has announced the selection of seven...
Regeneron Pharmaceuticals
Advertisement
Innovent’s IBI343 Shows Strong Efficacy in Phase III Study, Eyes Regulatory Approval
SAN FRANCISCO and SUZHOU, China, June 4, 2026 Innovent Biologics has announced a major breakthrough in precision oncology as...
CytomX and Regeneron Expand $4B Cancer Immunotherapy Alliance
SOUTH SAN FRANCISCO, California, USA, June 3, 2026 CytomX Therapeutics has announced a significant expansion of its strategic research...
Regeneron ISEF 2026 Awards Young STEM Innovators
PHOENIX, Arizona, May 15, 2026 The Regeneron International Science and Engineering Fair (ISEF) 2026, the world’s largest pre-college STEM...
Regeneron Science Talent Search Awards $1.8M to Students
Tarrytown, New York — March 10, 2026 Global biotechnology leader Regeneron Pharmaceuticals has celebrated the achievements of America’s most...
Advertisement
